Westlake Chemical Partners
WLKP
52 hedge funds and large institutions have $242M invested in Westlake Chemical Partners in 2024 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 15 reducing their positions, and 7 closing their positions.
732% more call options, than puts
Call options by funds: $1.36M | Put options by funds: $164K
6% more capital invested
Capital invested by funds: $228M → $242M (+$13.7M)
5.65% less ownership
Funds ownership: 35.34% → 29.69% (-5.7%)
7% less funds holding
Funds holding: 56 → 52 (-4)
27% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 15
29% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 7
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
+$4.32M |
| 2 |
Goldman Sachs
New York
|
+$1.82M |
| 3 |
Morgan Stanley
New York
|
+$751K |
| 4 |
Mirae Asset Global ETFs Holdings
Causeway Bay,
Hong Kong
|
+$652K |
| 5 |
Allspring Global Investments
Charlotte,
North Carolina
|
+$209K |
Top Sellers
WLKP Hedge Fund Activity: Q4 2024 in Review
52 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Westlake Chemical Partners (WLKP) for Q4 2024, worth a combined $242M — up 6% from $228M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of WLKP and 5 opened new positions — a net loss of 2 holders — while 15 trimmed existing stakes and 11 added.
The largest buyer was UBS Group, adding an estimated $4.32M. The largest seller was Pathway Financial Advisers, cutting an estimated $48.8M.
- 52 institutional investors held Westlake Chemical Partners (WLKP) as of Q4 2024, down from 56 in Q3 2024.
- Funds reported $242M of Westlake Chemical Partners stock for Q4 2024, up 6% quarter-over-quarter.
- 5 funds opened new Westlake Chemical Partners positions in Q4 2024 and 7 closed out, a net change of -2 holders.
- The largest Westlake Chemical Partners buyer in Q4 2024 was UBS Group, an estimated $4.32M added.
- The largest Westlake Chemical Partners seller in Q4 2024 was Pathway Financial Advisers, an estimated $48.8M sold.
Based on aggregated 13F filings for Q4 2024.